Randomised, blinded, placebo controlled trial of doxycycline for chronic seronegative arthritis

Annals of the Rheumatic Diseases

Volumn 60, Issue 12, 2001, Pages 1088-1094

  Smieja, M ^a   Macpherson, D W ^a   Kean, W ^a   Schmuck, M L ^a   Goldsmith, C H ^a   Buchanan, W ^a   Hart, L E ^a   Mahony, J B ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; PLACEBO;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC ARTHRITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REACTIVE ARTHRITIS; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ARTHRITIS; ARTHRITIS, REACTIVE; CHRONIC DISEASE; DOUBLE-BLIND METHOD; DOXYCYCLINE; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 0035191390     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.60.12.1088     Document Type: Article

References (36)

1. Reiter's syndrome
2. Report on the Fourth International Workshop on Reactive Arthritis
3. Reiter's syndrome and reactive arthritis in perspective
4. Post-salmonella reactive arthritis: Late clinical sequelae in a point source cohort
5. Evidence of Chlamydia trachomatis infection in sexually acquired reactive arthritis
6. Reactive arthritis in patients attending an urban sexually transmitted diseases clinic
7. The course of Reiter's syndrome
8. Reactive arthritis: The role of bacterial antigens in inflammatory arthritis
9. Beta haemolytic streptococci and reactive arthritis in adults
10. Chlamydia pneumoniae - A new causative agent of reactive arthritis and undifferentiated oligoarthritis
11. Clinically silent infections in patients with oligoarthritis: Results of a prospective study
12. Pathogenetic role of chlamydia, yersinia and borrelia in undifferentiated oligoarthritis
13. Chlamydia and associated arthritis
14. Chlamydia trachomatis and reactive arthritis: The missing link
15. Chlamydia and Reiter's syndrome (reactive arthritis)
16. Recurrent attacks in Reiter's disease
17. Light and electron microscopic studies on the synovial membrane in Reiter's syndrome. Immunocytochemical identification of chlamydial antigen in patients with early disease
18. Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction
19. Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. I. Screening of synovial fluid samples of patients with spondyloarthropathies and other arthritides
20. The detection of DNA from a range of bacterial species in the joints of patients with a variety of arthritides using a nested, broad-range polymerase chain reaction
21. Clinical trial of lincomycin hydrochloride in Reiter's disease
22. Early antibiotic treatment of reactive arthritis associated with enteric infections: Clinical and serological study
23. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to chlamydia arthritis
24. AIMS2. The content and properties of a revised and expanded arthritis impact measurement scales health status questionnaire
25. Measuring health status in arthritis. The arthritis impact measurement scales
26. The arthritis impact measurement scales. Further investigations of a health status measure
27. Sensitivity of a health status measure to short-term clinical changes in arthritis
28. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population
29. Minocycline in the treatment of patients with Reiter's syndrome
30. Long-term antibiotic treatment in reactive arthritis
31. Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis
32. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: A three-month, multicenter, double-blind, randomized, placebo-controlled study
33. Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis
34. Antibiotic prophylaxis and treatment of reactive arthritis. Lessons from an animal model
35. Alteration of Chlamydia trachomatis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome
36. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression